2020-08-17 Jan TunĂ©r, DDS, author and lecturer, Sweden
Using photobiomodulation (PBM) in the rehabilitation phase of Covid-19 patients seems logical in the light of decades of literature on the effects of selected light sources on inflammation and pain. Several pharmacological substances have already been tried as emergency interventions and with uncertain outcomes. PBM has been used for 50 years and the absence of serious side effects makes this adjuvant therapy a serious candidate for further investigations.